Journal of Medicinal Chemistry · 2001 · 224 citations · 9 references
PharmacyBiochemistryMedicinal ChemistryDrug DesignDrug DiscoveryStructural BiologyAmyloid FormationEnzyme InhibitionLead Compound DesignLead DiscoveryProtein DesignProtein StructureAmyloid FibrilsAmyloid StructureBeta Secretase InhibitionCrystal Structure AnalysisInhibitor PerformancePeptide Lead DiscoveryStructure-based Lead DiscoveryStructure-guided Lead Discovery
Memapsin 2 (beta-secretase) is one of two proteases that cleave the beta-amyloid precursor protein (APP) to produce the 40-42 residue amyloid-beta peptide (Abeta) in the human brain, a key event in the progression of Alzheimer's disease. On the basis of the X-ray crystal structure of our lead inhibitor (2, OM99-2 with eight residues) bound to memapsin, we have reduced the molecular weight and designed potent memapsin inhibitors. Structure-based design and preliminary structure-activity studies have been presented.
9
Structure of the Protease Domain of Memapsin 2 (β-Secretase) Complexed with Inhibitor
Hong Lin, Gerald Koelsch, Xinli Lin et al. · Science · 2000 · 706 citations
Michael Farzan, Christine E. Schnitzler, Natalya Vasilieva et al. · Proceedings of the National Academy of Sciences · 2000 · 399 citations